21-035
Showing 1 - 25 of 5,112
Glioblastoma Trial in Worldwide (Surgery followed by adjuvant second-line therapy, Second-line therapy alone)
Recruiting
- Glioblastoma
- Surgery followed by adjuvant second-line therapy
- Second-line therapy alone
-
Innsbruck, Austria
- +21 more
May 10, 2022
Non-hodgkin's Lymphoma Trial in Beijing (GNC-035)
Not yet recruiting
- Non-hodgkin's Lymphoma
-
Beijing, Beijing, ChinaBeijing Cancer Hospital
Sep 27, 2023
Relapsed/Refractory Chronic Lymphocytic Leukemia Trial in Tianjin (GNC-035)
Not yet recruiting
- Relapsed/Refractory Chronic Lymphocytic Leukemia
-
Tianjin, Tianjin, ChinaInstitute of Hematology and Blood Diseases Hospital, Chinese Aca
Jul 13, 2023
Renal Cell Carcinoma Trial in Worldwide (Nivolumab, Ipilimumab, Ipilimumab )
Active, not recruiting
- Renal Cell Carcinoma
- Nivolumab
- +2 more
-
Washington, District of Columbia
- +77 more
Jan 6, 2023
Patterns and Outcomes in Human Epidermal Growth Factor Receptor
Active, not recruiting
- Breast Cancer
-
Graz, Austria
- +52 more
Jun 20, 2022
COPD (COPD) Trial in Worldwide (Tozorakimab, Placebo)
Not yet recruiting
- Chronic Obstructive Pulmonary Disease (COPD)
- Tozorakimab
- Placebo
-
Lincoln, California
- +113 more
Feb 15, 2023
Macular Degeneration Trial in Worldwide (Aflibercept (Eylea, VEGF Trap-Eye, BAY86-5321))
Completed
- Macular Degeneration
- Aflibercept (Eylea, VEGF Trap-Eye, BAY86-5321)
-
Wien, Austria
- +70 more
Jun 1, 2021
Reproductive and Sexual Health in People With Early Onset
Recruiting
- Colorectal Cancer
- +2 more
- Hormone biomarker analysis
- QoL Questionnaires
-
Hartford, Connecticut
- +7 more
Sep 8, 2022
Endurant Stent Graft Natural Selection Global Postmarket
Completed
- Aortic Aneurysm, Abdominal
- Endurant Stent Graft
-
Buenos Aires, Argentina
- +79 more
Jan 26, 2022
Brimonidine Tartrate 0.025%/Ketotifen Fumarate 0.035%
Not yet recruiting
- Allergic Conjunctivitis
- rimonidine Tartrate 0.025%/Ketotifen Fumarate 0.035% Ophthalmic Solution (Combo)
- Vehicle of brimonidine tartrate 0.025%/ketotifen fumarate 0.035% ophthalmic solution
- (no location specified)
Apr 4, 2023
HIV Prevention Trial in Worldwide (Placebo rectal insert, Placebo rectal suppository, Placebo rectal douche)
Completed
- HIV Prevention
- Placebo rectal insert
- +2 more
-
Birmingham, Alabama
- +6 more
Jan 4, 2023
Infant Colic Trial in Cartagena (Lactoflora colicare, Reuteri gotas)
Recruiting
- Infant Colic
- Lactoflora colicare
- Reuteri gotas
-
Cartagena, Murcia, SpainUniversity Hospital Santa LucĂa
Feb 28, 2022
Vasomotor Symptoms Associated With Menopause, Hot Flashes Trial in Worldwide (Elinzanetant (BAY3427080), Placebo)
Active, not recruiting
- Vasomotor Symptoms Associated With Menopause
- Hot Flashes
- Elinzanetant (BAY3427080)
- Placebo
-
Birmingham, Alabama
- +98 more
Feb 2, 2023
Pulmonary Arterial Hypertension Trial in Worldwide (Riociguat (Adempas, BAY63-2521), Sildenafil, Tadalafil)
Completed
- Pulmonary Arterial Hypertension
- Riociguat (Adempas, BAY63-2521)
- +2 more
-
Phoenix, Arizona
- +80 more
Feb 3, 2021
Peripheral Arterial Disease Trial in Worldwide (Stellarex 0.035" Over-the-Wire (OTW) drug-coated angioplasty balloon (Stellarex
Active, not recruiting
- Peripheral Arterial Disease
- Stellarex 0.035" Over-the-Wire (OTW) drug-coated angioplasty balloon (Stellarex DCB)
-
Auchenflower, Australia
- +43 more
Mar 14, 2022
Breast Cancer Trial in Guangzhou (GNC-035)
Recruiting
- Breast Cancer
-
Guangzhou, Guangdong, ChinaSun Yat-sen Memorial Hospital
Dec 17, 2021
Critical Lower Limb Ischemia Trial in Mansoura (Trans-pedal access for endovascular revascularization in complex infra-popliteal
Completed
- Critical Lower Limb Ischemia
- Trans-pedal access for endovascular revascularization in complex infra-popliteal lesions in critically ischemic limb
-
Mansoura, EgyptMansoura University
Jun 25, 2022
Chemo-induced Thrombocytopenia Trial in Worldwide (Romiplostim, Placebo)
Recruiting
- Chemotherapy-induced Thrombocytopenia
- Romiplostim
- Placebo
-
Jonesboro, Arkansas
- +114 more
Nov 11, 2022
Uveitis Trial in United States (Izokibep, Prednisone/Prednisolone)
Active, not recruiting
- Uveitis
-
Los Angeles, California
- +3 more
Jul 18, 2022
Peripheral Artery Disease Trial in Shanghai (Orchid 035 DCB Catheter, POBA Catheter)
Recruiting
- Peripheral Artery Disease
- Orchid 035 DCB Catheter
- POBA Catheter
-
Shanghai, Shanghai, China
- +2 more
Feb 13, 2022
Chronic Heart Failure With Reduced Ejection Fraction Trial in Worldwide (Vericiguat, Placebo)
Recruiting
- Chronic Heart Failure With Reduced Ejection Fraction
- Vericiguat
- Placebo
-
Alexander City, Alabama
- +406 more
Aug 1, 2022